The Impact of GLP-1 Receptor Agonists on Semen Parameters and the Hypothalamic–Pituitary–Gonadal Axis in Men with Obesity — A Literature Review
Background. Rising global obesity prevalence has coincided with a debated decline in semen quality. GLP-1 receptor agonists (GLP-1 RAs) are now widely used for weight reduction in men of reproductive age, raising questions about their effect on fertility, particularly relative to testosterone replacement therapy (TRT),...